Patents Assigned to Sharp
  • Patent number: 11481176
    Abstract: A display system includes: a divided image generator grouping divided images obtained by dividing a specific image according to the number of display devices, and generating a plurality of group images; a first image output processor that outputsoutputting, to a predetermined one of the display devices, each of the plurality of group images; a second image output processor outputting a second group image to one of the display devices on a latter stage when a first group image output from a video output device and the second group image output from one of the display devices on a former stage are input; a synthesized image generator extracting, from at least one of the first group image and the second group image, a plurality of the divided images to be displayed by a corresponding one of the display devices, and generating a synthesized image; and a display processor displaying the synthesized image.
    Type: Grant
    Filed: August 23, 2021
    Date of Patent: October 25, 2022
    Assignee: SHARP KABUSHIKI KAISHA
    Inventor: Mamoru Takaya
  • Patent number: 11480902
    Abstract: A sheet heating device includes: a heat roller including a lamp heater; a fixing frame supporting end parts of the heat roller and the lamp heater; and a heat-insulating cover member provided outside of the fixing frame. The fixing frame is disposed so as to cover the space above the heat roller. A plurality of heat retention spaces is provided inside of the cover member so as to be partitioned from one another and to be opened toward the fixing frame.
    Type: Grant
    Filed: October 27, 2021
    Date of Patent: October 25, 2022
    Assignee: SHARP KABUSHIKI KAISHA
    Inventor: Minoru Tomiyori
  • Patent number: 11481434
    Abstract: A computer-implemented method for contextually applying audio to an electronic media file, includes the following steps: parsing the electronic media file to determine at least one context of the electronic media file; comparing the at least one context of the electronic media file against a database of context tags corresponding to at least one context of a plurality of audio files; generating a ranked list of audio files corresponding to the comparison of the at least one context of the electronic media file against the database of context tags; selecting at least one audio file from the ranked list; and generating an output file containing the electronic media file and the at least one audio file.
    Type: Grant
    Filed: November 29, 2019
    Date of Patent: October 25, 2022
    Assignee: LOOK SHARP LABS, INC.
    Inventors: Nicholas Venti, Brian Karscig, Tyson S. McDowell
  • Patent number: 11480827
    Abstract: A liquid crystal display device includes a first substrate, a second substrate, a vertical alignment liquid crystal layer, and a plurality of pixels. Each of the pixels includes a reflective region for performing display in a reflection mode. The first substrate includes a reflective electrode including a first region located within each of the plurality of pixels and a second region located between any two pixels, of the plurality of pixels, adjacent to each other, a transparent insulating layer provided to cover the reflective electrode, and a pixel electrode formed from a transparent conductive material and provided on the transparent insulating layer in each of the plurality of pixels. The second substrate includes a counter electrode provided to be opposite to the pixel electrode and the reflective electrode.
    Type: Grant
    Filed: October 26, 2021
    Date of Patent: October 25, 2022
    Assignee: SHARP KABUSHIKI KAISHA
    Inventors: Takahiro Sasaki, Takashi Satoh, Ming Ni, Shuji Nishi, Keiichi Ina
  • Patent number: 11479542
    Abstract: The disclosed subject matter provides certain polymorphic forms of Compound (I) as well as pharmaceutical compositions comprising Compound (I) or such polymorphic forms, and methods of using or making such compounds and pharmaceutical compositions. It has now been discovered that Compound (I) can exist in multiple crystalline forms (polymorphs). One particular crystalline form, Form II, has been found to be more thermodynamically stable and, thus, likely more suitable for bulk preparation and handling than other polymorphic forms. Efficient and economic methods have been developed to prepare Compound (I) and Form II in high purity on a large scale. In animal studies, Form II has demonstrated safety and efficacy in treating depressive disorders and, when micronized, improved absorption compared to non-micronized Form II.
    Type: Grant
    Filed: May 27, 2020
    Date of Patent: October 25, 2022
    Assignees: CERECOR, INC., MERCK SHARP & DOHME CORP.
    Inventors: Reza Mazhari, Djelila Mezaache, Blake M. Paterson, James Vornov, Rachel M. Garner, Todd Nelson
  • Patent number: 11483880
    Abstract: A User Equipment (UE) includes a transmitter configured to, in a case that, at a time when a Public Land Mobile Network (PLMN) is changed, a first timer is deactivated for a certain Data Network Name (DNN) and an old PLMN but a second timer is not running for the DNN or a new PLMN and is not deactivated, be capable of transmitting a PDU session establishment request message for the DNN or no DNN in the new PLMN without stopping the first timer. Thus, a communication control method is provided that is used in a case that, in 5G congestion control in which multiple types of congestion control are applied, the PLMN is changed during application of the congestion control.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: October 25, 2022
    Assignees: SHARP KABUSHIKI KAISHA, FG Innovation Company Limited
    Inventors: Masafumi Aramoto, Tsuyoshi Takakura
  • Patent number: 11483826
    Abstract: A terminal apparatus includes: a monitor unit configured to monitor a first PDCCH candidate with aggregation level 8 and a second PDCCH candidate with aggregation level 16 in a CORESET mapped to one OFDM symbol; and a receiver configured to receive a PDSCH, by assuming that a symbol of the PDSCH is mapped to a resource element that is not overlapping the second PDCCH candidate, based on a PDCCH detected in the first PDCCH candidate, the PDCCH scheduling the PDSCH, wherein a CCE that constitutes the first PDCCH candidate and has a lowest index is identical to a CCE that constitutes the second PDCCH candidate and has a lowest index, and a plurality of the CCEs constituting the CORESET each include six contiguous REGs in a frequency domain.
    Type: Grant
    Filed: October 11, 2018
    Date of Patent: October 25, 2022
    Assignees: SHARP KABUSHIKI KAISHA, FG Innovation Company Limited
    Inventors: Shoichi Suzuki, Tomoki Yoshimura, Taewoo Lee, Wataru Ouchi, Liqing Liu
  • Patent number: 11478461
    Abstract: Disclosed herein are compounds of formula (I) which are inhibitors of an IDO enzyme: (I). Also disclosed herein are uses of the compounds in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising these compounds. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.
    Type: Grant
    Filed: April 15, 2019
    Date of Patent: October 25, 2022
    Assignee: Merck Sharp & Dohme LLC
    Inventors: Liangqin Guo, Hongjun Zhang, Ping Chen, Dane Clausen, Xavier Fradera, Yongxin Han, Shuwen He, Xianhai Huang, Alexander Pasternak, Qinglin Pu, Li Xiao, Feng Ye
  • Patent number: 11479615
    Abstract: Antibodies that bind the apple 3 domain of human coagulation Factor XI and inhibit activation of FXI by coagulation factor XIIa as well as activation of FIX by FXIa are described.
    Type: Grant
    Filed: May 1, 2020
    Date of Patent: October 25, 2022
    Assignees: Merck Sharp & Dohme LLC, Adimab, LLC
    Inventors: Zhu Chen, Kenneth Ellsworth, James Milligan, Elizabeth Oldham, Dietmar Seiffert, Bianka Prinz
  • Patent number: 11483055
    Abstract: The present invention provides user equipment and a beam failure recovery method. The beam failure recovery method for user equipment (UE), includes: receiving indication of beam failure instance; accumulating the number of received indications so as to obtain an accumulative value; initiating a beam failure recovery procedure when the accumulative value is greater than a first threshold; and skipping processing the received indication of beam failure instance during the beam failure recovery period. Thus, it is possible to eliminate false beam failures.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: October 25, 2022
    Assignees: SHARP KABUSHIKI KAISHA, FG INNOVATION COMPANY LIMITED
    Inventors: Chao Luo, Shohei Yamada, Renmao Liu
  • Patent number: 11482185
    Abstract: A method for driving a display device capable of appropriately performing idle driving even when timing information is not transmitted to a liquid crystal module in advance is provided. In a case where, in one vertical period, a non-scanning period other than a scanning period in which a screen of a display unit is scanned once is set to a pause period, a liquid crystal module delays supply of a data signal to the display unit by a recovery period during which a source driver is recovered from a sleep state to an active state in the pause period.
    Type: Grant
    Filed: July 25, 2018
    Date of Patent: October 25, 2022
    Assignee: SHARP KABUSHIKI KAISHA
    Inventors: Yuta Tanaka, Kazuo Nakamura, Kazuki Takahashi, Jin Miyazawa
  • Patent number: 11483784
    Abstract: A base station apparatus provided with a function of performing communication using multiple beams implements appropriate beamforming while reducing interference power, thereby communication quality becomes stable and frequency efficiency or throughput is improved. The base station apparatus according to the present invention is a base station apparatus for communicating with a terminal apparatus, the base station apparatus including: a transmitter configured to transmit a synchronization signal block including a synchronization signal in a prescribed transmission window; and a controller configured to configure a size of the prescribed transmission window in which the synchronization signal block is transmitted, in which the transmitter notifies the terminal apparatus of information associated with QCL between two of the synchronization signal blocks transmitted in the prescribed transmission window.
    Type: Grant
    Filed: February 5, 2019
    Date of Patent: October 25, 2022
    Assignees: SHARP KABUSHIKI KAISHA, FG Innovation Company Limited
    Inventors: Hiromichi Tomeba, Ryota Yamada, Hideo Nanba, Atsushi Shirakawa
  • Patent number: 11482833
    Abstract: A light emitting device includes a semiconductor light source device including a plurality of semiconductor light emitting elements, a wavelength conversion member that converts a wavelength of irradiation light from the semiconductor light source device, a concentrating lens that concentrates the irradiation light from the semiconductor light source device, and a cylindrical holder. The semiconductor light source device, the wavelength conversion member and the concentrating lens is supported by a support portion provided in an inner diameter portion of the cylindrical holder.
    Type: Grant
    Filed: February 12, 2020
    Date of Patent: October 25, 2022
    Assignee: SHARP KABUSHIKI KAISHA
    Inventors: Hiroaki Onuma, Toshio Hata, Yasuaki Hirano
  • Publication number: 20220331350
    Abstract: The present invention is directed to methods for inhibition of HIV reverse transcriptase, treatment of infection by HIV, prophylaxis of infection by HIV, and the treatment, prophylaxis and/or delay in the onset or progression of AIDS or ARC by administering a compound of structural Formula I or a pharmaceutically acceptable salt or co-crystal thereof, wherein X is —F or —Cl, less frequently than once daily.
    Type: Application
    Filed: April 8, 2022
    Publication date: October 20, 2022
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Daria Hazuda, Michael D. Miller, Jay A. Grobler, Deborah Anne Nicoll-Griffith
  • Publication number: 20220331321
    Abstract: Methods of treating malaria comprising administration of compounds of Formula (I?) or a pharmaceutically acceptable salt thereof, to a subject in need thereof, wherein the variables are as defined herein. It also provides uses of the compounds of Formula (I), as defined herein, for inhibiting plasmepsin X, plasmepsin IX or plasmepsin X and IX activity, for treating a Plasmodium infection, and for treating malaria. Also provided are methods of treatment further comprising administration of one or more additional anti-malarial compounds.
    Type: Application
    Filed: July 21, 2020
    Publication date: October 20, 2022
    Applicants: Merck Sharp & Dohme Corp., The Walter and Eliza Hall Institute of Medical Research, MSD R & D (China) Co. LTD.
    Inventors: John A. McCauley, Alan F. Cowman, Manuel de Lera Ruiz, Paola Favuzza, Zhuyan Guo, Bin Hu, Michael J. Kelly, III, Zhiyu Lei, David B. Olsen, Brad Sleebs, Jennifer K. Thompson, Tony Triglia, Dongmei Zhan, Cailing Zhang, Lianyun Zhao
  • Publication number: 20220334040
    Abstract: Embodiments of the present invention provide an apparatus and method for determining whether a dosage unit of a pharmaceutical dmg disintegrates in an immersion fluid of a disintegration tester within a prescribed time limit and to record and transmit to human-accessible output devices the times required. In one implementation, the apparatus comprises a computer system, a motion sensor, a capture device, a fastener for attaching the capture device and motion sensor to the reciprocating arm of the disintegration tester, and one or more data communications interfaces to carry commands and data between the computer system, the motion sensor and the capture device.
    Type: Application
    Filed: September 29, 2020
    Publication date: October 20, 2022
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Grace Chen, Joanna C. Everitt, Sydney Floryanzia, Janakiraman Gopinath, Prashant I. Shah
  • Patent number: 11476282
    Abstract: An active matrix substrate includes gate bus lines; source bus lines; a lower insulating layer; an oxide semiconductor TFT; and a pixel electrode, in which the oxide semiconductor TFT includes an oxide semiconductor layer disposed on the lower insulating layer, a gate electrode, a source electrode, and a first ohmic conductive portion that is coupled to the oxide semiconductor layer and the source electrode, the lower insulating layer includes a source opening portion exposing at least a portion of the source electrode, the first ohmic conductive portion is disposed on the lower insulating layer and in the source opening portion and is in direct contact with at least the portion of the source electrode in the source opening portion, and the first region of the oxide semiconductor layer is in direct contact with an upper surface of the first ohmic conductive portion.
    Type: Grant
    Filed: August 4, 2020
    Date of Patent: October 18, 2022
    Assignee: SHARP KABUSHIKI KAISHA
    Inventors: Yoshihito Hara, Tohru Daitoh, Hajime Imai, Masaki Maeda, Tatsuya Kawasaki, Hideki Kitagawa, Yoshiharu Hirata
  • Patent number: 11477776
    Abstract: A user equipment (UE) is described. Receiving circuitry is configured to receive a radio resource control (RRC) message including information used for configuring more than one periodicities, each of the more than one periodicities corresponding to each of more than one uplink bandwidth parts (UL BWPs). The receiving circuitry is also configured to receive on a physical downlink control channel (PDCCH), a downlink control information format used for scheduling of a physical uplink shared channel (PUSCH), the downlink control information format being used for activating one UL BWP among the more than one UL BWPs. Transmitting circuitry is configured to perform, based on a periodicity among the more than one periodicities, an uplink transmission on the PUSCH in the activated one UL BWP. The periodicity among the more than one periodicities is determined based on the activated one UL BWP in which the uplink transmission is performed on the PUSCH.
    Type: Grant
    Filed: January 9, 2019
    Date of Patent: October 18, 2022
    Assignees: SHARP KABUSHIKI KAISHA, FG Innovation Company Limited
    Inventors: Tatsushi Aiba, John Michael Kowalski, Kamel M. Shaheen, Zhanping Yin
  • Patent number: 11476314
    Abstract: A display device according to the disclosure includes a substrate, a first transistor provided on the substrate, and a second transistor provided on the substrate, not overlapping the first transistor. The first transistor includes a polycrystalline silicon layer provided on the substrate, a first insulating film provided on the polycrystalline silicon layer, a first gate electrode provided on the first insulating film, and a second insulating film provided on the first gate electrode. The second transistor includes an oxide semiconductor layer provided on the first insulating film, a third insulating film provided on the oxide semiconductor layer, and a second gate electrode provided on the third insulating film. The first and third insulating films are SiOx films. The second insulating film is an SiNx film including hydrogen, and is provided overlapping the polycrystalline silicon layer, and is provided not overlapping the oxide semiconductor layer.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: October 18, 2022
    Assignee: SHARP KABUSHIKI KAISHA
    Inventors: Masatomo Honjo, Hiroshi Matsukizono, Takuya Matsuo
  • Patent number: 11471512
    Abstract: Disclosed are pharmaceutical compositions comprising the peptide of SEQ ID No. 1, or a pharmaceutically acceptable salt or counterion thereof, methods of preparing such pharmaceutical compositions, and methods of treating diabetes and diabetes-related disorders with such pharmaceutical compositions.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: October 18, 2022
    Assignee: Merck Sharp & Dohme LLC
    Inventors: Himanshu Bhattacharjee, Suzanne M. D'Addio, Sachin Lohani, Sachin Mittal, Sergei Y. Pechenov, Daniel Hong Yin